---
title: "R vs SAS: Cost, Speed, Career & What Fortune 500s Are Using"
slug: "R-vs-SAS"
description: "R vs SAS compared on licensing costs, performance, FDA compliance, job market, and enterprise adoption. An objective guide for analysts weighing the switch."
keywords: "R vs SAS, SAS vs R, R or SAS, SAS alternative, R for enterprise, SAS migration, R FDA compliance, R pharma"
mathjax: false
webr: false
date: "2026-03-29"
curriculum_id: "CMP3"
post_type: "FR"
auto_link_terms: "R vs SAS|SAS vs R|R or SAS"
auto_link_case_sensitive: false
fr_parent: "Is-R-Worth-Learning-in-2026.html"
---

# R vs SAS: Cost, Speed, Career & What Fortune 500s Are Using

<p class="lead">SAS has been the enterprise standard for statistics and analytics for 40+ years. R is the open-source challenger that Fortune 500 companies, the FDA, and major pharma firms are increasingly adopting. Here's how they compare on cost, capability, career prospects, and compliance.</p>

SAS and R serve overlapping markets but come from very different philosophies. SAS is a commercial product with world-class support and regulatory track records. R is a community-driven open-source language with unmatched statistical depth. Understanding the trade-offs is critical if you're choosing between them — or planning a migration.

## Licensing and Cost

The cost difference is dramatic and is the single biggest factor driving enterprise R adoption.

| Factor | R | SAS |
|--------|---|-----|
| Base license | Free (GPL-2) | $8,000-50,000+/year per user |
| Enterprise deployment | Free | $150,000-1,000,000+/year |
| Cloud (SAS Viya) | N/A | Subscription (6-7 figures for enterprise) |
| Additional modules | Free (CRAN packages) | $5,000-25,000 each |
| Support | Community + Posit (paid option) | Included with license |
| Total cost of ownership (50 users) | Near zero (software) | $500K-2M+/year |

**SAS advantage:** The license includes support, training, documentation, and guaranteed stability. For regulated industries, this "one throat to choke" model has real value.

**R advantage:** The money saved on licensing can be invested in people, training, and infrastructure. Organizations with 50+ analysts can save millions annually by switching to R.

## Statistical and Analytical Capabilities

| Capability | R | SAS |
|------------|---|-----|
| Classical statistics | Comprehensive (21,000+ packages) | Comprehensive (PROC-based) |
| Machine learning | tidymodels, caret, xgboost | SAS Viya, Enterprise Miner |
| Deep learning | torch, keras | SAS DLPy (limited) |
| Bayesian statistics | brms, rstanarm, JAGS | PROC MCMC (limited) |
| Time series | forecast, fable, tseries | PROC ARIMA, PROC ESM |
| Text analytics | quanteda, tidytext | SAS Text Miner |
| Visualization | ggplot2 (best-in-class) | PROC SGPLOT (adequate) |
| Spatial analysis | sf, terra, leaflet | SAS/GIS (limited) |
| Bioinformatics | Bioconductor (2,200+ pkgs) | SAS Genetics (limited) |

**R advantage:** New statistical methods appear on CRAN within months of publication. In SAS, you wait for the next release cycle — if the method is added at all. R's package ecosystem is orders of magnitude larger.

**SAS advantage:** SAS procedures are battle-tested and produce consistent, well-documented output. PROC SQL, PROC MEANS, PROC REG have been refined over decades.

## Performance and Scalability

| Aspect | R | SAS |
|--------|---|-----|
| In-memory processing | Default (data.table is very fast) | Default |
| Larger-than-memory data | arrow, duckdb, sparklyr | SAS can handle larger datasets natively |
| Parallel processing | future, furrr, foreach | Built-in (threaded procedures) |
| Database integration | DBI, dbplyr | Built-in (PROC SQL, libname) |
| Distributed computing | sparklyr, Rmpi | SAS Grid Manager, SAS Viya |

**SAS advantage:** SAS was designed for large enterprise datasets from day one. It handles datasets that don't fit in memory without special configuration. SAS Grid Manager provides enterprise-grade distributed computing.

**R advantage:** With `data.table`, `arrow`, and `duckdb`, R can process billions of rows efficiently. The `sparklyr` package connects R to Spark clusters for true big data workloads.

## FDA Compliance and Regulated Industries

This is the most important section for pharma and healthcare readers.

**SAS's regulatory history:** SAS has been used in FDA submissions for 30+ years. Pharma companies trust it because regulators are familiar with SAS output, and SAS Institute provides validation documentation.

**R's regulatory status in 2026:** R is fully accepted by the FDA. Key milestones:

- The FDA uses R internally for statistical review
- The R Consortium's R Submissions Working Group has successfully completed pilot FDA submissions using R
- The `pharmaverse` — a collection of R packages for clinical trials — provides validated, GxP-compliant tools
- Major pharma companies (Roche, Pfizer, Novartis, J&J) have adopted R for regulatory submissions

```r
# Example: The pharmaverse provides validated clinical trial tools
# admiral: creates ADaM datasets
# teal: builds interactive Shiny apps for clinical data review
# rtables: creates regulatory-compliant tables

library(admiral)
library(rtables)

# These packages follow ICH E9 guidelines and produce
# submission-ready output accepted by the FDA
```

**Key R validation resources:**
- `riskmetric` package: quantifies R package risk for validation
- R Validation Hub (pharmar.org): industry-wide effort to establish R validation frameworks
- `valtools`: tools for creating validated R packages in GxP environments

**Verdict:** As of 2026, R is a fully viable choice for FDA submissions. The pharma industry's migration from SAS to R is well underway.

## Job Market and Career Impact

| Metric | R | SAS |
|--------|---|-----|
| LinkedIn job postings (US, 2026) | ~15,000/month | ~8,000/month |
| Salary trend | Rising | Flat to declining |
| Median salary (data analyst) | $85,000 | $90,000 |
| Median salary (data scientist) | $125,000 | $115,000 |
| New graduates learning | Growing rapidly | Declining |
| Industry direction | Adoption increasing | Legacy maintenance |

**SAS career reality:** SAS skills still command decent salaries, especially in banking, insurance, and government. But new SAS projects are rare. Most SAS jobs involve maintaining existing systems.

**R career reality:** R skills are in demand for data science, biostatistics, research, and analytics roles. R knowledge often comes paired with modern data science skills (Git, cloud, ML), making R users more versatile.

**The generational shift:** University statistics departments increasingly teach R instead of SAS. The pipeline of new SAS users is shrinking, while the R community grows.

## Enterprise Adoption

Fortune 500 companies using R:
- **Google**: Uses R for analytics and causal inference research
- **Facebook/Meta**: R for experimentation analysis
- **Microsoft**: Invested in R (acquired Revolution Analytics), Azure ML supports R
- **Roche, Pfizer, Novartis**: Migrating clinical trials infrastructure to R
- **The New York Times, BBC, Financial Times**: R for data journalism and visualization

SAS's enterprise strongholds:
- Banking and financial services (risk modeling, fraud detection)
- Government agencies (Census Bureau, defense)
- Insurance (actuarial, claims analysis)
- Legacy pharma (gradually migrating)

## Migration Strategy: SAS to R

If your organization is considering the switch, here's a practical approach:

**Phase 1 (Months 1-3):** Pilot project
- Pick one non-critical analysis workflow
- Replicate SAS output in R
- Use `haven::read_sas()` to import SAS datasets
- Map SAS PROCs to R equivalents

**Phase 2 (Months 3-6):** Training and tooling
- Train team on tidyverse, ggplot2, R Markdown
- Set up RStudio Server or Posit Workbench for team access
- Establish coding standards and package validation processes

**Phase 3 (Months 6-12):** Gradual migration
- Move new projects to R
- Keep SAS running for legacy workflows
- Build R validation documentation for regulatory needs

| SAS Procedure | R Equivalent |
|---------------|-------------|
| PROC MEANS | `summary()`, `dplyr::summarise()` |
| PROC FREQ | `table()`, `janitor::tabyl()` |
| PROC REG | `lm()` |
| PROC LOGISTIC | `glm(family = binomial)` |
| PROC MIXED | `lme4::lmer()` |
| PROC SORT | `dplyr::arrange()` |
| PROC SQL | `dplyr` verbs or `sqldf` |
| PROC SGPLOT | `ggplot2` |
| DATA step | `dplyr::mutate()`, `dplyr::filter()` |
| PROC EXPORT | `readr::write_csv()`, `haven::write_sas()` |

## FAQ

**Q: Is SAS dying?**
A: SAS isn't dying, but it's declining. SAS Institute still generates $3+ billion in annual revenue, and existing installations will run for years. However, new adoptions are rare, and the trend is clearly toward open-source tools.

**Q: Will the FDA reject my submission if I use R instead of SAS?**
A: No. The FDA has publicly stated it accepts submissions using any validated software. The R Submissions Working Group has completed successful pilot submissions. Multiple pharma companies now submit using R.

**Q: Can I run SAS code in R?**
A: Not directly, but the `haven` package reads SAS datasets (.sas7bdat), and the translation from SAS PROCs to R functions is straightforward. The `sasr` package can interface with a SAS installation if you need to run both during migration.

## Continue Learning
- [Is R Worth Learning in 2026?](/Is-R-Worth-Learning-in-2026.html) -- Evidence-based analysis of R's position in the market
- [R vs Python](/R-vs-Python.html) -- The other major comparison every data professional faces
- [R Data Scientist Career](/R-Data-Scientist-Career.html) -- Career paths, salaries, and skills for R professionals
